COMPULSORY EXERCISE. 8.1 Notwithstanding any other provision of this Warrant, the Company may by written notice to the Warrantholder, require that the Warrantholder exercise some or all of its outstanding purchase rights, provided that: 8.1.1 such notice may not be given by the Company prior to December 24, 2022; 8.1.2 as at the date of notice the Shares are listed on the Nasdaq Global Market; and 8.1.3 as at the date of notice, the ten-day volume weighted average price of the Shares as reported on the Nasdaq Global Market represents a premium of at least 50 per cent to the Exercise Price. 8.2 Within five Business Days of receipt by the Warrantholder of the notice referred to in clause 8.1, the Warrantholder shall exercise such number of its purchase rights as are specified in the Exercise Notice of the Company in accordance with clause 2.5.
Appears in 3 contracts
Sources: Warrant Agreement (Zanganeh Maky), Warrant Agreement (Duggan Robert W), Warrant Agreement (Summit Therapeutics Inc.)